# A Placebo-controlled Crossover Trial Using Cyproheptadine To Treat Children With Functional Abdominal Pain

> **NCT01675050** · PHASE2 · TERMINATED · sponsor: **University of Michigan** · enrollment: 4 (actual)

## Conditions studied

- Functional Abdominal Pain

## Interventions

- **DRUG:** Cyproheptadine
- **DRUG:** sugar pill

## Key facts

- **NCT ID:** NCT01675050
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-08
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Due to the wide availability of the drug in clinical practice, it was impossible to recruit adequate numbers for scientific power.
- **Last updated:** 2017-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01675050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01675050, "A Placebo-controlled Crossover Trial Using Cyproheptadine To Treat Children With Functional Abdominal Pain". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01675050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*